Hu Z, Kimura G, Mawatari S, Shimokawa T, Yoshikawa Y, Takada K
Department of Pharmacokinetics, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8414, Japan.
J Control Release. 1998 Dec 4;56(1-3):293-302. doi: 10.1016/s0168-3659(98)00090-x.
A new method for preparing large amounts of pressure-controlled colon delivery capsules (PCDCs) which employs a pharmaceutical coating machine, Hicoater-mini, has been developed. In contrast to our original method for preparing PCDCs where the inner surfaces of gelatin capsule were coated with the water-insoluble polymer ethylcellulose (EC), PCDC were directly prepared by coating the capsular shaped suppositories with EC. As a model drug, fluorescein (FL) was used in this study. FL powder was suspended with the suppository base, polyethylene glycol (PEG) 1000, at 50 degreesC, and was hardened in the capsular shape the sizes of which were #0 and #2. The capsular shaped suppositories were coated with 5% w/v ethanolic EC (7G grade) solution by a coating machine. By increasing the coating time from 55 to 75 min, the mean coating thickness of #0 PCDCs increased from 141+/-7 to 211+/-4 micrometer. In the case of #2 PDDCs, the mean coating thickness increased from 102+/-3 to 110+/-5 micrometer by increasing the coating time from 35 min to 40 min. Several kinds of #0 PCDCs having the mean EC coating membrane thickness of 141+/-7 micrometer (type 1), 166+/-4 micrometer (type 2), 188+/-4 micrometer (type 3), 211+/-4 micrometer (type 4) as well as #2 PCDCs having thickness of 102+/-3 micrometer (type 5) and 110+/-5 micrometer (type 6) were used for in vivo evaluation using beagle dogs. After oral administration of the test preparations containing 30 mg of FL, blood samples were obtained from the jugular vein and plasma FL levels were measured. The first appearance time, Ti, of FL in the plasma was used as a parameter for the estimation of the release time of FL from PCDCs in the gastrointestinal tract. The mean Ti of #0 PCDCs were 2.3+/-0.5 for type 1, 3.3+/-0.5 for type 2, 4.8+/-1.0 for type 3 and 7.8+/-1.7 h for type 4 preparations while the mean Ti of #2 PCDCs were 3.2+/-0.4 for type 5 and 3.8+/-0.4 h for type 6, respectively. There were good correlations between EC coatings.
已开发出一种使用制药包衣机Hicoater-mini制备大量压力控制结肠递送胶囊(PCDC)的新方法。与我们最初制备PCDC的方法不同,最初的方法是在明胶胶囊的内表面涂上水不溶性聚合物乙基纤维素(EC),而PCDC是通过用EC包衣胶囊形状的栓剂直接制备的。在本研究中,使用荧光素(FL)作为模型药物。将FL粉末与栓剂基质聚乙二醇(PEG)1000在50℃下悬浮,并在尺寸为#0和#2的胶囊形状中硬化。通过包衣机用5%w/v乙醇EC(7G级)溶液包衣胶囊形状的栓剂。通过将包衣时间从55分钟增加到75分钟,#0 PCDC的平均包衣厚度从141±7增加到211±4微米。对于#2 PDDC,通过将包衣时间从35分钟增加到40分钟,平均包衣厚度从102±3增加到110±5微米。几种平均EC包衣膜厚度为141±7微米(1型)、166±4微米(2型)、188±4微米(3型)、211±4微米(4型)的#0 PCDC以及厚度为102±3微米(5型)和110±5微米(6型)的#2 PCDC用于使用比格犬进行体内评估。口服含有30mg FL的测试制剂后,从颈静脉采集血样并测量血浆FL水平。血浆中FL的首次出现时间Ti用作估计FL从PCDC在胃肠道中释放时间的参数。#0 PCDC的1型平均Ti为2.3±0.5小时,2型为3.3±0.5小时,3型为4.8±1.0小时,4型制剂为7.8±1.7小时,而#2 PCDC的5型平均Ti为3.2±0.4小时,6型为3.8±0.4小时。EC包衣之间存在良好的相关性。